Investors & media
Financial data
Find the latest press releases, financial information, and performance updates.
Transforming rare disease care
We are a global specialty biopharmaceutical company expanding possibilities for people with rare diseases. With 50 years of experience in applying our scientific expertise and unique technologies to research, we continue to develop next-generation treatments and expand our global footprint to transform the lives of patients worldwide.
Newsroom
2026.04.13
JCR Pharmaceuticals initiates phase III dose comparison study of GROWJECT™ S.C. injection 12mg in Japan
2026.04.01
JCR Pharmaceuticals launches redesigned corporate website
2026.02.26
Announcement of executive appointments and organizational changes
2026.02.26
JCR establishes Advanced Biopharmaceutical Research Institute
2026.02.20
JCR Pharmaceuticals supports Rare Disease Day 2026
Performance data and annual reports
JCR Pharmaceuticals (4552.T)
Tokyo Currency in JPY
616.00
+45.00
(+7.88%)
Last updated 04/17/2026 at TSE market close
Quarterly results
Annual reports
Driven by science and compassion, we tackle some of the most complex challenges in rare disease. Every solution we develop is grounded in insight into the genetic and biological foundations of the conditions we aim to treat.
Contact us
Investors & media